Terpos E - Search Results

1

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.

Caers J, Garderet L, Kortüm KM, O'Dwyer ME, van de Donk NWCJ, Binder M, Dold SM, Gay F, Corre J, Beguin Y, Ludwig H, Larocca A, Driessen C, Dimopoulos MA, Boccadoro M, Gramatzki M, Zweegman S, Einsele H, Cavo M, Goldschmidt H, Sonneveld P, Delforge M, Auner HW, Terpos E, Engelhardt M. Caers J, et al. Among authors: terpos e. Haematologica. 2018 Nov;103(11):1772-1784. doi: 10.3324/haematol.2018.189159. Epub 2018 Aug 31. Haematologica. 2018. PMID: 30171031 Free PMC article. Review.

2

Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.

Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A. Terpos E, et al. Int J Cancer. 2003 Sep 1;106(3):455-7. doi: 10.1002/ijc.11247. Int J Cancer. 2003. PMID: 12845688 Free article.

3

Bisphosphonate treatment for multiple myeloma.

Terpos E, Rahemtulla A. Terpos E, et al. Drugs Today (Barc). 2004 Jan;40(1):29-40. doi: 10.1358/dot.2004.40.1.799436. Drugs Today (Barc). 2004. PMID: 14988768 Review.

4

The role of markers of bone remodeling in multiple myeloma.

Terpos E, Politou M, Rahemtulla A. Terpos E, et al. Blood Rev. 2005 May;19(3):125-42. doi: 10.1016/j.blre.2004.06.001. Blood Rev. 2005. PMID: 15748961 Review.

5

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.

Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, Scott GL, Rahemtulla A, Samson D, Apperley JF. Terpos E, et al. Eur J Haematol. 2005 Nov;75(5):376-83. doi: 10.1111/j.1600-0609.2005.00531.x. Eur J Haematol. 2005. PMID: 16191086

6

Anti-angiogenic effect of bortezomib in patients with multiple myeloma.

Politou M, Naresh K, Terpos E, Crawley D, Lampert I, Apperley JF, Rahemtulla A. Politou M, et al. Among authors: terpos e. Acta Haematol. 2005;114(3):170-3. doi: 10.1159/000087894. Acta Haematol. 2005. PMID: 16227683 No abstract available.

7

Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.

Dimopoulos MA, Anagnostopoulos A, Terpos E, Repoussis P, Zomas A, Katodritou E, Kyrtsonis MC, Delibasi S, Vassou A, Pouli A, Zervas K, Anagnostopoulos N, Maniatis A; Greek Myeloma Study Group. Dimopoulos MA, et al. Among authors: terpos e. Haematologica. 2006 Feb;91(2):252-4. Haematologica. 2006. PMID: 16461313 Clinical Trial.

8

Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.

Politou MC, Heath DJ, Rahemtulla A, Szydlo R, Anagnostopoulos A, Dimopoulos MA, Croucher PI, Terpos E. Politou MC, et al. Among authors: terpos e. Int J Cancer. 2006 Oct 1;119(7):1728-31. doi: 10.1002/ijc.22033. Int J Cancer. 2006. PMID: 16646053 Free article.

9

Biochemical markers of bone metabolism in multiple myeloma.

Terpos E. Terpos E. Cancer Treat Rev. 2006;32 Suppl 1:15-9. doi: 10.1016/s0305-7372(06)80004-6. Cancer Treat Rev. 2006. PMID: 16680833 Review.

10

Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.

Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D, Moulopoulos LA, Bamia C, Terpos E, Tsionos K, Bamias A. Dimopoulos MA, et al. Among authors: terpos e. Haematologica. 2006 Jul;91(7):968-71. Epub 2006 Jun 1. Haematologica. 2006. PMID: 16757414 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

745 results

Search Page